Lucinfig

Sobre este medicamento

Originator: Truseltiq by QED Therapeutics, Inc. · Manufacturer: Lucius Pharma. Indication & Dosage: Lucinfig (Infigratinib), generic Truseltiq is a prescription medicine used to treat of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma whose tumors harbor a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement, as confirmed by an FDA-approved diagnostic test. Lucinfig manufactured by Lucius Pharma Ltd. In Laos. Infigratinib has to take orally once daily for 21 days after meals, followed by 7 days off therapy. Side Effects: The most common side effects of Infigratinib are: Headache, Abdominal pain, Nausea, Abdominal distension, Dizziness. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.